Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-10-20FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for ALENDRONATE SODIUM from Amneal Pharmaceuticals of New York LLC, authorizing an additional regula…
-
CLINICAL_TRIALS trial_result · 2009-10-05Clinical Trial Update: A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation [Phase 1]
This is a Phase 1 study evaluating the effect of food on the intermittent formulation of ONO-5920/YM529 for osteoporosis. The trial status i…
-
CLINICAL_TRIALS trial_result · 2009-09-30Clinical Trial Update: Phase 3 Clinical Trial of Teriparatide in Japan [Phase 3]
Phase 3 clinical trial of teriparatide for osteoporosis conducted in Japan has completed, with results posted on 2009-09-30.
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week [Phase 4]
This Phase 4 trial (ROSPA) assessing patient satisfaction with Actonel 35 mg once weekly in osteoporosis was terminated.
-
FDA approval · 2009-09-24FDA Approved: ALENDRONATE — Original Application (Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.)
FDA approved Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.'s generic alendronate (alendronate sodium tablets) via an Original Applicat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-09-24Clinical Trial Update: A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal Women [Phase 2]
Phase 2 dose-selection trial evaluating oral recombinant salmon calcitonin for osteoporosis in healthy postmenopausal women; the study is co…
-
CLINICAL_TRIALS trial_result · 2009-09-14Clinical Trial Update: Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass [Phase 4]
Phase 4 trial evaluating whether acetaminophen or fluvastatin reduces transient post-dose symptoms after an intravenous zoledronic acid 5 mg…
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: Danish Osteoporosis Prevention Study [Phase 4]
This Clinical Trials update reports that a Phase 4 osteoporosis prevention trial conducted by the University of Aarhus has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-26Clinical Trial Update: A Study for Patients With Osteoporosis [Phase 3]
A Phase 3 trial evaluating an osteoporosis therapy sponsored by Eli Lilly has completed, with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-08-21Clinical Trial Update: Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women [Phase 3]
Phase 3 trial evaluating TSE-424, placebo, and raloxifene for osteoporosis prevention in postmenopausal women has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-12Clinical Trial Update: Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L ) [Phase 3]
This report notes the termination of a Phase 3 trial evaluating the combination of Alendronate and Leuprolide (Lupron) for osteoporosis in p…
-
FDA approval · 2009-07-22FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories, indicating changes to the product's labeling …
-
CLINICAL_TRIALS trial_result · 2009-07-10Clinical Trial Update: Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis [Phase 2]
Phase 2 trial comparing ViaDerm-hPTH(1-34) to Forteo (teriparatide) in postmenopausal osteoporosis provides efficacy and safety data.
-
CLINICAL_TRIALS trial_result · 2009-07-10Clinical Trial Update: Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis [NA]
A completed clinical trial evaluating drug holidays in the treatment with alendronate for osteoporosis in postmenopausal women.
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: Study of the Osteoprotector Effects of a Milk Product Based on Anthocyans and Enriched in Calcium and Vitamin D [Phase 2]
Phase 2 study evaluating a milk product enriched with anthocyans, calcium, and vitamin D for osteoporosis has been completed.
-
CLINICAL_TRIALS research · 2009-07-03Clinical Trial Update: An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice
An open-label, non-interventional study assessing how adjuvant aromatase inhibitors affect bone mineral density and fracture risk in postmen…
-
CLINICAL_TRIALS trial_result · 2009-06-24Clinical Trial Update: Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy [Phase 3]
Phase 3 trial assessing osteoporosis patients self-administering daily teriparatide with the Forteo B Pen; results were posted in 2009.
-
CLINICAL_TRIALS research · 2009-06-24Clinical Trial Update: Radiostereometric Analysis of Acetabular Wear and Periprosthetic Bone Mineral Density Changes in Hemiarthroplasties [NA]
This clinical trial update describes the use of radiostereometric analysis to measure acetabular wear and changes in periprosthetic bone min…
-
FDA approval · 2009-06-08FDA Approved: CALCITONIN SALMON — Original Application (Endo USA, Inc.)
FDA approved Endo USA, Inc.'s Original Application for Calcitonin Salmon (generic), confirming a generic product for the drug. The approval …
-
CLINICAL_TRIALS trial_result · 2009-05-18Clinical Trial Update: A Study to Estimate the Effect of Formulation on the Relative Absorption of SB-751689 Administered to Healthy Women [Phase 1]
Phase 1 study assessing the effect of formulation on the relative absorption of SB-751689 in healthy women; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2009-05-18Clinical Trial Update: A Study To Evaluate The Effects Of Repeat Dosing Of Esomeprazole On The Pharmacokinetics Of SB-751689 In Healthy People [Phase 1]
This Phase 1 study evaluated whether repeat dosing of esomeprazole alters the pharmacokinetics of SB-751689 in healthy participants; the tri…
-
CLINICAL_TRIALS trial_result · 2009-05-18Clinical Trial Update: A Study To Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal Women [Phase 1]
Phase 1 metabolism and excretion study of SB-751689 in healthy men and postmenopausal women has completed.
-
CLINICAL_TRIALS research · 2009-05-12Clinical Trial Update: Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer [NA]
Clinical trial update evaluating hormone replacement therapy to relieve menopausal symptoms in postmenopausal women with a history of Stage …
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Risedronate in the Prevention of Osteoporosis in Postmenopausal Women [Phase 4]
This Phase 4 trial update reports on risedronate for the prevention of osteoporosis in postmenopausal women; the study status is completed.
-
CLINICAL_TRIALS research · 2009-04-09Clinical Trial Update: Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects [Phase 2]
Phase 2 clinical trial update on androgen therapy for breast cancer patients experiencing aromatase inhibitor-induced side-effects, such as …